Literature DB >> 10364618

Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection.

D Tranchand-Bunel1, H Gras-Masse, B Bourez, L Dedecker, C Auriault.   

Abstract

An immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) was developed by using a 24-amino-acid peptide of the 18-kDa Epstein-Barr virus (EBV) viral capsid antigen (VCAp18). IgM detection was increased by 23% by using this antigen. Detection of IgM antibodies to the EBV proteins in the new ELISA was 100% specific and 95% sensitive.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10364618      PMCID： PMC85167     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Convergent peptide libraries, or mixotopes, to elicit or to identify specific immune responses.

Authors:  H Gras-Masse; B Georges; J Estaquier; D Tranchand-Bunel; A Tartar; P Druilhe; C Auriault
Journal:  Curr Opin Immunol       Date:  1999-04       Impact factor: 7.486

2.  Detection of human antibodies using "convergent" combinatorial peptide libraries or "mixotopes" designed from a nonvariable antigen: application to the EBV viral capsid antigen p18.

Authors:  D Tranchand-Bunel; C Auriault; E Diesis; H Gras-Masse
Journal:  J Pept Res       Date:  1998-12

Review 3.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

Review 4.  Infectious mononucleosis.

Authors:  S H Cheeseman
Journal:  Semin Hematol       Date:  1988-07       Impact factor: 3.851

5.  Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex.

Authors:  W M van Grunsven; A Nabbe; J M Middeldorp
Journal:  J Med Virol       Date:  1993-06       Impact factor: 2.327

6.  Rapid diagnosis of acute Epstein-Barr virus infection by an indirect enzyme-linked immunosorbent assay for specific immunoglobulin M (IgM) antibody without rheumatoid factor and specific IgG interference.

Authors:  D W Ho; P R Field; A L Cunningham
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

7.  False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children.

Authors:  D Levine; R C Tilton; M F Parry; R Klenk; A Morelli; N Hofreuter
Journal:  Pediatrics       Date:  1994-12       Impact factor: 7.124

8.  The rapid serological diagnosis of infectious mononucleosis.

Authors:  J J Gray; J Caldwell; M Sillis
Journal:  J Infect       Date:  1992-07       Impact factor: 6.072

9.  Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology.

Authors:  M Linderholm; J Boman; P Juto; A Linde
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

10.  Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.

Authors:  W M van Grunsven; W J Spaan; J M Middeldorp
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226
View more
  3 in total

1.  Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Authors:  Nina Orlova; Mark H Fogg; Angela Carville; Fred Wang
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

2.  Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.

Authors:  P Rao; H Jiang; F Wang
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein.

Authors:  Catherine Delbende; Claudie Verwaerde; Alexandra Mougel; Denis Tranchand Bunel
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.